PHARMACEUTICAL IP

  • Our Offering
    • Fractional in-house
    • Start-ups
    • Established pharma
    • International IP counsel
    • Investors
    • Due diligence
  • Fractional in-house
  • Sectors
    • Pharmaceuticals
    • Biotechnology
    • Biologics
    • Cell & gene therapies
    • AI drug discovery
    • Chemistry
  • Insights
    • Articles
    • Webinars
    • Subscribe
  • About us
    • Our team
    • Join us
    • Contact us
  • Our Offering
    • Fractional in-house
    • Start-ups
    • Established pharma
    • International IP counsel
    • Investors
    • Due diligence
  • Fractional in-house
  • Sectors
    • Pharmaceuticals
    • Biotechnology
    • Biologics
    • Cell & gene therapies
    • AI drug discovery
    • Chemistry
  • Insights
    • Articles
    • Webinars
    • Subscribe
  • About us
    • Our team
    • Join us
    • Contact us
  • Our offering
  • Fractional in-house
  • Sectors
  • Articles
  • Our team
  • Join us
  • Our offering
  • Fractional in-house
  • Sectors
  • Articles
  • Our team
  • Join us

Insights

Welcome to Evolve Insights!

Evolve Insights is your go-to source for expert analysis and strategic perspectives on pharmaceutical IP.

  • Visit our pharma IP Blog for the latest pharma IP news, analysis and perspectives.
  • Register for our upcoming live webinars and watch our previous webinars on-demand.
  • Subscribe to our newsletter to stay up to date.

Do you have questions about how the latest developments in IP might impact you? Our team of experts would love to hear from you.

Latest articles

All articles

Launch of Evolve Webinars!

  • 25th June 2025
A series of live webinars on IP strategy for pharma & biotech professionals.

Are AI-discovered drug patents blocking innovation? A response to the Science article

  • 25th June 2025
Are AI-discovered drug patents truly blocking innovation, or does a new Science article on the topic misunderstand on how pharma IP strategy?

The morality (and patentability) of inventions derived by immoral means (T 2510/18)

  • 25th June 2025
Should patents be granted for inventions born from unethical practices, even if they offer significant societal benefits?

Webinars

All webinars
  • Upcoming

Unlocking the potential of cell & gene therapies with effective IP strategy

Upcoming date: July 11, 2025, 1:00 pm BST
Discover how to transform ground-breaking cell & gene therapy science into commercial success with robust IP strategies.

Stay connected

Get the latest insights, news, and expert analysis on pharmaceutical IP delivered straight to your inbox.
Subscribe for updates

evolve® is a trading entity of Evolve Intellectual Property Limited. Evolve Intellectual Property Limited is regulated by the Intellectual Property Regulation Board (IPReg). Details of the UK professional rules can be found on the IPReg website

registered address: 49 Greek Street, London, England, W1D 4EG

website out of house

© 2025 All Rights Reserved

Keep in touch

Subscribe

Contact Us